Objective: The Cox-Maze IV procedure has been shown to be an effective treatment for atrial fibrillation when performed concomitantly with other operations either via median sternotomy or right minithoracotomy. Few studies have compared these approaches in patients with lone atrial fibrillation. This study examined outcomes with sternotomy versus minithoracotomy in stand-alone Cox-Maze IV procedures at our institution. Methods: Between 2002 and 2015, 195 patients underwent stand-alone biatrial Cox-Maze IV. Minithoracotomy was used in 75 patients, sternotomy in 120. Freedom from atrial tachyarrhythmias was ascertained using electrocardiography, Holter, or pacemaker interrogation at 3 to 60 months. Predictors of recurrence were determined using logistic regression. Results: Of 23 preoperative variables, the only differences between groups were that minithoracotomy patients had a higher rate of New York Heart Association 3/4 symptoms and a lower rate of previous stroke. Minithoracotomy and sternotomy patients had similar atrial fibrillation duration and type. Minithoracotomy patients had a smaller left atrial diameter (4.5 vs 4.8 cm, P = 0.03). More minithoracotomy patients received a box lesion (73/75 vs 100/120, P = 0.002). Minithoracotomy patients had a shorter hospital stay (7 vs 8 days, P = 0.009) and a similar rate of major complications (3/75 (4%) vs 7/120 (6%), P = 0.74). There were no differences in mortality or freedom from atrial tachyarrhythmias. Predictors of atrial fibrillation recurrence included a preoperative pacemaker, omission of the left atrial roof line, and New York Heart Association 3/4 symptoms. Conclusions: Stand-alone Cox-Maze IV via minithoracotomy was as effective as via sternotomy with a shorter hospital stay. A minimally invasive approach is our procedure of choice.
T he first successful surgical ablation for atrial fibrillation (AF) was performed by Dr James L. Cox in 1987 . 1 The last iteration of this operation, the Cox-Maze III procedure, became the criterion standard for the treatment of AF for over a decade. In this procedure, surgical incisions in both atrium were used to create lines of conduction block to prevent AF. During the 2000s, the introduction of the use of ablation devices by our group and others made surgical ablation for AF safer and more widely performed. [2] [3] [4] In 2002, a modified Cox-Maze procedure using ablation devices to replace most of the atrial incisions, the Cox-Maze IV (CMIV), was introduced and has been widely accepted. Most of surgical ablation of AF is performed concomitantly with other cardiac surgical procedures, especially mitral valve surgery. Our group has previously shown that a minimally invasive approach is as effective as a median sternotomy approach for a mixed group of patients, most of whom underwent concomitant procedures. 5 There is a growing evidence base that concomitant surgical ablation should be considered standard of care for patients with preoperatively diagnosed AF undergoing cardiac surgery.
Patients undergoing stand-alone surgical ablation for AF represent a very different patient population. These patients have frequently undergone multiple trials of antiarrhythmic drug therapy as well as failed catheter ablation procedures. In our experience, their atria are frequently scarred, and have undergone significant remodeling. In the last multispecialty consensus statement, the indications for surgical ablation in patients with lone AF include patients with symptomatic AF refractory or intolerant to at least one Vaughan-Williams class I or III antiarrhythmic drug who have failed catheter or prefer a surgical approach. 6 Because these patients have no other cardiac pathology, it is imperative that procedures performed in these patients be as safe and effective as possible. Weimar et al 7 last reported our center's experience with this procedure in 2012, including patients who underwent a Cox-Maze III or a CMIV. The CMIV procedure was as effective as the Cox-Maze III with shorter operative times and a lower rate of major complications. Over the past decade, numerous groups have also introduced less invasive surgical approaches. In 2013, Ad et al 8 published a series of 104 stand-alone Cox-Maze procedures performed using cryothermal energy through a right minithoracotomy (RMT) with 80% of patients free from AF and antiarrhythmic drugs (AADs) at 36 months. Moten et al 9 have had similar results with a minimally invasive Cox-Maze procedure using cryothermal ablation. They reported a 41-patient series in 2007 with 87% of patients in sinus rhythm at 1 year. However, neither of these series directly compared their novel minimally invasive procedures to a traditional open approach. The purpose of this study was to compare a minimally invasive CMIV procedure performed with bipolar radiofrequency ablation and cryoablation to a CMIV procedure using the same ablation technology via a median sternotomy approach.
METHODS
The institutional review board at our institution approved this study, and written informed consent was obtained from each patient before their enrollment. Over 400 demographic and perioperative variables were prospectively entered into The Society of Thoracic Surgeons database and a longitudinal database maintained at our institution.
Patient Population
Between January 2002 and October 2015, 195 consecutive patients underwent stand-alone biatrial CMIV at our institution. Our group has previously published detailed descriptions of the CMIV operative technique, performed via a median sternotomy or a RMT. 10, 11 Briefly, the steps of the RMT approach to the operation are as follows. The patient is positioned supine, and general anesthesia is induced. A double-lumen endotracheal tube, a radial arterial line, and a central venous catheter are placed. Transesophageal echocardiography is used to confirm the absence of thrombus in the left atrial appendage. The right chest is then elevated to a 30-to 45-degree angle. The patient is marked, prepared, and draped in sterile fashion. Femoral cannulation for cardiopulmonary bypass is obtained via a cutdown. The guidewires and cannulae are advanced into the descending thoracic aorta and the right atrium using transesophageal echocardiography visualization. A 5-to 6-cm minithoracotomy is then made over the fourth intercostal space lateral to the nipple in the midaxillary line in men; a submammary incision is used in women. A small segment of the posterior fifth rib is removed, and a soft tissue retractor is used to improve visualization. A Blake drain is placed through the lateral chest wall, and carbon dioxide is infused to prevent air embolism.
After the pericardium is opened, a thoracoscope is placed through a port in the sixth intercostal space near the posterior axillary line. The superior vena cava (SVC) and inferior vena cava (IVC) are mobilized, and the right pulmonary veins are dissected. The right pulmonary veins are dissected and encircled with umbilical tape. Pacing thresholds are obtained from the right pulmonary veins. The right pulmonary veins are then isolated using three sequential ablations of a cuff of atrial tissue around the veins with a bipolar radiofrequency device. Ablation is continued until exit block is obtained. Exit block is tested by pacing the pulmonary veins at two times the previously documented pacing threshold while monitoring the surface electrocardiogram for capture.
The CMIV lesion set is shown in schematic form in Figure 1A . The right atrial lesions are created on cardiopulmonary bypass but before aortic cross-clamping. Three purse-string sutures are placed: one above the interatrial septum midway between the SVC and the IVC, one on the right atrial free wall near the atrioventricular groove, and one at the base of the right atrial appendage. The bipolar radiofrequency clamp that is placed through the first purse-string suture is used to create three lesions: one toward the SVC, one toward the IVC, and one along the right atrial free wall. The device is fired three times with slight changes in position for each lesion. The second pursestring suture is placed at the end of the free wall lesion. A reusable linear cryoprobe is placed endocardially through the purse-string toward the tricuspid annulus at the 1 o'clock position. This cryoablation is performed by freezing to −60°C for three minutes, as are all subsequent cryoablations. The third purse-string suture is opened with a stab incision, and the bipolar radiofrequency clamp is used to make a lesion toward the SVC at least 2 cm away from the previous SVC lesion. An endocardial cryoablation is then made to the tricuspid annulus at the 11 o'clock position with the linear cryoprobe.
The left atrium is then dissected and opened in the interatrial groove. Exposure is obtained using an atrial lift retractor. The bipolar radiofrequency clamp is used to make "roof " and "floor" lesions from the atriotomy to the left superior and inferior pulmonary veins, respectively. The clamp is also used to create an ablation from the inferior margin of the atriotomy toward the mitral annulus, taking care to avoid the circumflex coronary artery. As the bipolar clamp cannot reach the annulus itself, a bell-shaped cryoprobe is used to make an endocardial lesion to the mitral annulus and an epicardial lesion over the coronary sinus. The left atrial "box" is completed by using a linear cryoprobe to create a lesion behind the left pulmonary veins, along the lateral ridge, connecting the roof and floor lesions. The left atrial appendage is managed by oversewing its orifice in two layers from an endocardial approach.
The median sternotomy lesion set is shown in Figure 1B . It is similar to the RMT lesion set but includes a right atriotomy and left pulmonary vein isolation using the bipolar radiofrequency clamp. The left atrial appendage is amputated and oversewn rather than endocardially oversewing it with the sternotomy approach.
It should be noted that in 2005, the CMIV was modified to include a superior connecting "roof " lesion between the left and right superior pulmonary veins, which has been shown to improve freedom from atrial tachyarrhythmias (ATAs) (Fig. 1) . 12, 13 This box lesion was performed in 100 (83%) of 120 patients undergoing CMIV via a median sternotomy and in 73 (97%) of 75 patients undergoing CMIV via RMT. Preoperative and perioperative variables were retrospectively evaluated and compared.
Follow-up
Freedom from atrial tachyarrhythmias and from antiarrhythmic drugs at 1, 2, 3, 4, and 5 years were evaluated by electrocardiogram or by prolonged monitoring (24-hour Holter, pacemaker interrogation, or implantable loop recorder interrogation), as recommended by consensus guidelines. 6 Success was defined as freedom from ATAs (AF, atrial flutter, or atrial tachycardia) after a 3-month blanking period as defined by consensus guidelines. 6 As a part of routine postoperative care, patients were maintained on class I or III AADs and warfarin for at least 2 months after surgery unless they had specific contraindications. The AADs were discontinued at 2 months if normal sinus rhythm was maintained; anticoagulation was discontinued at 3 months if no AF was found on prolonged monitoring, and no left atrial stasis was found on echocardiography. Calcium channel blockers and β blockers were not considered to be AADs.
Mean follow-up was 2.9 ± 1.9 years. 
Statistical Analysis
Continuous variables were expressed as mean ± SD or as median with range. Student t test was used to compare means of normally distributed continuous variables. The Mann-Whitney U nonparametric test was used to compare distributions of skewed continuous variables. Categorical variables were expressed as frequencies and percentages, and outcomes were compared using the χ 2 test or Fisher exact test. Twenty-three preoperative and perioperative variables were evaluated in univariate logistic regression to identify potential predictors of ATA recurrence at 1 year. Significant covariates (P < 0.10) and factors believed to be significant predictors of recurrence in our clinical experience were entered into a multivariable logistic regression model. All statistical analyses were performed using R version 3.2.5 (R Foundation, Vienna, 2016).
RESULTS Demographics
Preoperative demographic data are shown in Table 1 . The mean overall age was 58 ± 10 years, and 136 (69.7%) of 195 of the population were men. Of the overall cohort, 55 (28.2%) of 195 of the population had paroxysmal AF, 12 (6.2%) of 195 had 
Perioperative Results
Perioperative outcomes are summarized in Table 2 . A box lesion was more commonly used in RMT patients (73/75 [97%] vs 100/120 [83%], P = 0.002). Perfusion and crossclamp times were both longer with the minimally invasive approach (160 ± 27 vs 124 ± 27 minutes and 64 ± 17 vs 39 ± 13 minutes, respectively, P < 0.001). There were no differences in overall major complications or 30-day mortality; there was only one early death, in the sternotomy group. Median hospital length of stay was one day shorter in the RMT group (7 [ 
Follow-up
Freedom from ATAs and freedom from ATAs and AADs were not significantly different between groups at 1, 2, 3, 4 or 5 years. Freedom from ATAs is shown in Figure 2 . As shown in Figure 3 , excluding patients who did not receive complete isolation of the posterior left atrial wall, freedom from ATAs and AADs was 80% at 1 year in the RMT group and 90% in the sternotomy group. Freedom from ATAs and AADs at 5 years was 71% (10/14) in the RMT group and 59% (24/41) in the median sternotomy group, as shown in Figure 3 .
Multivariable analysis revealed that omission of the left atrial roof line, preoperative NYHA class III or IV symptoms, diabetes mellitus, and the presence of a preoperative pacemaker were significant risk factors for recurrent ATAs at 12 months, as shown in Table 3 .
DISCUSSION
The results of this study lend support to the concept that a minimally invasive approach to stand-alone surgical ablation for 4 (5) 10 ( AF provides patients with a faster recovery while maintaining the efficacy of the traditional median sternotomy approach. There were no significant differences between groups in freedom from ATAs or in freedom from ATAs and AADs at any time point. Although operative times were longer with the minimally invasive approach, this was not associated with higher rates of major complications or mortality.
This study adds to the literature supporting the efficacy of a modified Cox-Maze procedure using ablation devices. Weimar et al 7 from our group have previously shown the CMIV using bipolar radiofrequency clamps and cryoablation to have equivalent freedom from AF compared with the cut-and-sew CoxMaze III procedure with a lower rate of major complications. Ad et al 8 have established the safety and efficacy of a standalone minimally invasive Cox-Maze procedure performed using cryothermal energy alone. The CMIV procedure has also been shown to be effective in large cohorts of patients undergoing stand-alone and concomitant procedures. 14 The present study also represents an important contribution to the body of literature showing the superiority of the full biatrial Cox-Maze lesion set over more limited lesion sets for stand-alone surgical treatment of AF. In this series, omission of the left atrial roof line, leaving the left atrial posterior wall in electrical continuity with the anterior and superior left atrium, is associated with a significantly increased rate of atrial tachyarrhythmia recurrence.
Many small series of totally epicardial and hybrid operations using varied lesion sets have been published in the medical literature over the past several years. This work has been summarized in a systematic review by Je et al 15 in 2015. After reviewing 37 studies including 1877 patients, they found that patients undergoing minimally invasive full Cox-Maze procedures had a significantly higher rate of freedom from AF at 1 year than those who underwent fully epicardial or hybrid procedures. In their review, a full Cox-Maze procedure also had important safety advantages over epicardial or hybrid procedures including lower rates of conversion to median sternotomy and reoperation for bleeding. Notably, results from our center were not included in the meta-analysis. The freedom from ATAs and complication rates in the present series were similar to those reported in that review.
This study has several limitations. First, this is a retrospective cohort study performed at a single institution, with most of the cases performed by a single surgeon, introducing potential bias. Second, there is a possibility of temporal confounding. As our practice evolved, we have had less enthusiasm for the median sternotomy approach to stand-alone surgical ablation. The applicability of these results to surgeons starting new programs is limited, as the surgeons performing these cases were already proficient in surgical ablation before this case series. Third, some of the follow-up in this case series was not performed according to current reporting guidelines, and not all patients had prolonged monitoring at each follow-up time point.
In summary, this study showed a minimally invasive CMIV procedure via an RMT to be as effective as the CMIV procedure via a traditional median sternotomy with a shorter hospital stay. These findings should encourage the broader adoption of a minimally invasive approach to stand-alone surgical ablation of AF using the full biatrial Cox-Maze lesion set. 
CLINICAL PERSPECTIVE
The optimal treatment for atrial fibrillation (AF) for symptomatic patients who failed medical therapy is in constant debate. The decision on the recommended mode of treatment for a given patient represents the most important conflict that patients and physicians have; it is how to balance invasiveness and effectiveness. When it comes to catheter ablation versus surgical ablation, this argument is valid. Catheter ablation, although less effective compared with surgical ablation, is much less invasive and therefore makes perfect sense as a first line of nonmedical treatment. The big challenges we have in the surgical community are to balance our approaches and to focus on outcomes to ensure a high rate of sinus rhythm using a much more invasive approach as compared with catheter-based techniques. In a recent report from The Society of Thoracic Surgeons database, it was clearly shown that most surgical procedures for standalone AF were performed using off-pump beating heart epicardial ablation. This trend should be assessed very carefully because it is based on the misconception that beating heart procedures are safer than those performed with cardiopulmonary bypass support. In a comparative analysis published by our group, it was clearly demonstrated that a minimally invasive full Cox-Maze procedure performed with the cardiopulmonary bypass support support may be considered safer when compared with beating heart procedures performed by the leading surgeons in the field. Our study also showed that even in a relatively short follow-up, the efficacy of the Cox-Maze procedure is significantly higher compared with beating heart procedures, whether as a sole therapy or in combination with a catheter-based or hybrid approach.
In this article, Schill et al from Washington University demonstrated the safety and efficacy of both the median sternotomy and the right minithoracotomy approaches to apply the Cox-Maze lesion set. In 5 years' follow-up, they demonstrated an excellent success rate with a single intervention. The readers should be aware that any follow-up catheter ablation is considered a failure of the primary procedure, even if resulted in sinus rhythm. Therefore, a clear distinction should be made when reading reports on long-term success rate. The study from Washington University should encourage surgeons to openly discuss the best treatment options for their patients, especially when it comes to those with long-standing persistent AF.
